Thromboembolic events in people with cancer during the COVID-19 pandemic: case-control study.
Vivian Cristina Gama Souza Lima, Paulo Jorge Pereira Alves, Patrícia Dos Santos Claro Fuly
PMID 39166625WHAT IT FOUND
In adults with cancer, COVID-19 did not show an association with thromboembolic events.
Active cancer, chemotherapy, recent chemotherapy, transfusions and low hemoglobin were associated.
Key findings
01COVID-19 infection was not significantly associated with thromboembolic events in the studied adults with cancer.
02Thromboembolic events were associated with cancer and treatment factors, including active cancer, chemotherapy, recent chemotherapy, transfusions and low hemoglobin.
03Deep vein thrombosis was the most frequent thromboembolic event, followed by pulmonary embolism and cerebrovascular accident.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
It used retrospective medical records from one public oncology service, so findings may not apply to other hospitals or countries. Records were not created for research, so missing or inaccurate information could affect the associations. The study only covered the first year of the pandemic, before vaccination and rapid testing changed care. It is observational, so it shows associations, not proof that any treatment caused thromboembolic events. The Padua score was used because it was recorded, not because it was validated for this population.
Declared interests
The supplied text gives no author conflict or funding declaration. The article's metadata lists non-U.S. government research support.
The easy way to misread this
Do not read the null COVID-19 association as proof that cancer patients had no thromboembolic risk during the pandemic. The study still found associations with active cancer, chemotherapy, recent chemotherapy, transfusions and low hemoglobin, and it used records from a single oncology service during the first pandemic year.